The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

otsuka-global.com

About Otsuka

Provider of pharmaceuticals. The company provides pharmaceuticals focused on the central nervous system, the vascular and circulatory system, the digestive and respiratory systems, ophthalmology, and dermatology.

Otsuka Headquarter Location

Apt 55-56, El-Sarag Mall No 1 Off Makram Ebeid Street, Nasr City

Cairo,

Egypt

20 2 670 4001

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Otsuka

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Otsuka in 1 CB Insights research brief, most recently on Apr 6, 2021.

Expert Collections containing Otsuka

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Otsuka is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Otsuka Patents

Otsuka has filed 40 patents.

The 3 most popular patent topics include:

  • Polymers
  • Polymer chemistry
  • Geometrical optics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/4/2017

6/7/2022

Ion channels, Industrial machine manufacturers, Vehicle braking technologies, Brakes, Nanomaterials

Grant

Application Date

12/4/2017

Grant Date

6/7/2022

Title

Related Topics

Ion channels, Industrial machine manufacturers, Vehicle braking technologies, Brakes, Nanomaterials

Status

Grant

Latest Otsuka News

Otsuka : Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

Apr 28, 2022

04/28/2022 | 03:25am EDT Message : Code Number Contact Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation Otsuka Holdings Co., Ltd. (the "Company") announces that payment of disposal of treasury shares has been made as shown in the following table. For further information, please refer to "Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation" which was issued on March 30, 2022. Overview of the Disposal of Treasury Shares (1)Disposal date

  • Where is Otsuka's headquarters?

    Otsuka's headquarters is located at Apt 55-56, El-Sarag Mall No 1, Cairo.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.